INOTEK PHARMACEUTICALS CORP - COM (ITEK)

CUSIP: 45780V102

Q4 2015 13F Holders as of 31 Dec 2015

Type / Class
Equity / COM
Total 13F shares
19,217,106
Share change
+537,883
Total reported value
$217,725,768
Price per share
$11.33
Number of holders
60
Value change
+$6,681,357
Number of buys
29
Number of sells
23

Quarterly Holders Quick Answers

What is CUSIP 45780V102?
CUSIP 45780V102 identifies ITEK - INOTEK PHARMACEUTICALS CORP - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of INOTEK PHARMACEUTICALS CORP - COM (ITEK) as of Q4 2015

As of 31 Dec 2015, INOTEK PHARMACEUTICALS CORP - COM (ITEK) was held by 60 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 19,217,106 shares. The largest 10 holders included Devon Park Associates, LLC, RHO CAPITAL PARTNERS INC, JENNISON ASSOCIATES LLC, RS INVESTMENT MANAGEMENT CO LLC, FRANKLIN RESOURCES INC, Point72 Asset Management, L.P., PRICE T ROWE ASSOCIATES INC /MD/, EverPoint Asset Management, LLC, BlackRock Advisors LLC, and VANGUARD GROUP INC. This page lists 60 institutional shareholders reporting positions in this security for the Q4 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.